Promethazine is not an opioid. It is a first-generation antihistamine in the phenothiazine family, prescribed for nausea, allergies, motion sickness, and sedation before or after surgery. The confusion almost always traces back to one thing: promethazine’s long-standing pairing with codeine in prescription cough syrups, a combination that became a fixture in recreational drug culture under names like “lean” and “purple drank.” That association has muddied public understanding of what promethazine actually is and does in the body.
What Promethazine Actually Is
Promethazine hydrochloride is classified as a first-generation H1 receptor antagonist, meaning it blocks histamine receptors to reduce allergic reactions, nausea, and vomiting.1PubMed Central. Topical promethazine side effects: our experience and review of the literature Histamine is the chemical your body releases during an allergic response, and blocking it is how older allergy medications like diphenhydramine (Benadryl) work too. Promethazine belongs to that same general class, though it also has strong antiemetic properties, making it useful for severe nausea and post-surgical vomiting.
The sedation that promethazine produces is one reason people sometimes lump it in with opioids. It can make you very drowsy, sometimes profoundly so. But that drowsiness comes from antihistamine activity in the brain, not from binding to opioid receptors. Opioids like morphine, oxycodone, and codeine work by attaching to mu-opioid receptors, which is how they relieve pain and produce euphoria. Promethazine does not interact with those receptors at all. Its chemical ancestry actually ties it to antipsychotic medications: chlorpromazine, the first modern antipsychotic, was synthesized in 1950 as a derivative of the same phenothiazine family, originally during research into antihistamines that could be used as pre-anesthetic medications.2PubMed Central. The story of antipsychotics: Past and present Promethazine is a cousin of antipsychotics, not opioids.
Why People Confuse It With an Opioid
The main reason for the confusion is a single product: prescription cough syrup containing both codeine and promethazine. In a medical setting, this combination makes sense. Codeine suppresses coughing and provides mild pain relief. Promethazine adds antihistamine and sedative effects that help with upper respiratory symptoms in adults.3PubMed Central. Codeine and promethazine: Exploratory study on “lean” or “sizzurp” using national survey data and an online forum The two drugs complement each other for treating a miserable cough, and the combination has been prescribed for decades.
Outside the doctor’s office, that same syrup became the base ingredient of “lean,” also called “purple drank” or “sizzurp,” typically mixed with soda and sometimes candy. The concoction holds a prominent place in popular culture, frequently referenced in music, social media, and entertainment.4PLOS ONE. Codeine and promethazine: Exploratory study on “lean” or “sizzurp” using national survey data and an online forum Rap artists in particular have promoted its calming and euphoric effects through songs and videos, giving it mainstream visibility.5PubMed. “Purple Drank” (Codeine and Promethazine Cough Syrup): A Systematic Review of a Social Phenomenon with Medical Implications Because the product is known by a single street name and consumed as a single drink, many people don’t realize it contains two separate drugs with entirely different mechanisms. They hear “codeine-promethazine” as one thing and assume both ingredients are opioids.
The euphoria users experience from lean comes from the codeine, which is metabolized into morphine in the body. Promethazine is along for the ride, but it plays a specific supporting role that makes the experience feel different from codeine alone.
How Promethazine Amplifies Opioid Effects
Even though promethazine is not itself an opioid, it meaningfully changes how opioids feel. Promethazine’s sedative and central nervous system depressant properties intensify and prolong the drowsy, relaxed state that opioids produce.3PubMed Central. Codeine and promethazine: Exploratory study on “lean” or “sizzurp” using national survey data and an online forum It is also thought to potentiate the subjective “high” from opioids, making the combination more appealing to people misusing them.6PubMed Central. Promethazine use among chronic pain patients This potentiation effect is the pharmacological reason the two keep showing up together, not just in lean but across a range of misuse patterns.
Research on chronic pain patients has documented how tightly the two drugs are linked in practice. In one study, about 9% of chronic pain patients had promethazine-positive urine samples, and only half of those patients actually had an active prescription for promethazine, suggesting the other half obtained it through other channels.6PubMed Central. Promethazine use among chronic pain patients The association was especially strong among patients on methadone: those with methadone-positive urine had roughly three times the odds of also testing positive for promethazine. Patients receiving methadone maintenance for opioid dependence showed a similar pattern. Even patients prescribed only a long-acting opioid (as opposed to a short-acting one) had about twice the odds of using promethazine on the side.6PubMed Central. Promethazine use among chronic pain patients
The pattern is clear: people who use opioids, whether by prescription or otherwise, disproportionately seek out promethazine to enhance the experience. That consistent pairing reinforces the public perception that promethazine must be an opioid itself, when it is actually a pharmacological booster riding alongside one.
Health Risks When Promethazine and Opioids Are Combined
The same potentiation that makes the combination appealing also makes it dangerous. Consuming large quantities of both drugs together prolongs and intensifies each drug’s sedative effects and increases the risk of life-threatening events including delirium, respiratory depression, overdose, and dangerous heart rhythm changes.6PubMed Central. Promethazine use among chronic pain patients Respiratory depression is the primary killer in opioid overdoses, and promethazine’s own sedative load makes it harder for the brain to maintain the drive to breathe.
Data from the European Medicines Agency paints a grim picture. Out of over 1,500 reported adverse drug reactions involving promethazine, more than a third were related to abuse, misuse, or dependence. Among those cases, over half ended in death, and the fatalities were most commonly recorded as drug toxicity or drug abuse cases where opioids were the most frequently reported co-used drugs.7Journal of Psychopharmacology. Beyond the ‘purple drank’: Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports That fatality rate is strikingly high, and the consistent presence of opioids in those deaths underscores that promethazine’s danger is greatest when it is used alongside drugs that already depress breathing.
Promethazine also carries a black box warning, the most serious safety label the FDA uses, regarding respiratory depression in children younger than two years old. That warning was added in November 2004 after reports of fatal breathing problems in very young children given the drug.8Hospital Pharmacy. Promethazine Prescribing Patterns in Pediatric Inpatients Younger than Two Years before and after the Product Black Box Warning The warning is not about opioid-like activity, but it does highlight that promethazine on its own can suppress respiration under certain conditions, particularly in developing nervous systems.
Can Promethazine Be Misused on Its Own?
Yes, and this is a point that often surprises people. Even without an opioid in the picture, promethazine has its own abuse potential. Data from U.S. poison centers on cases of intentional promethazine abuse or misuse found a range of clinical effects:
- Drowsiness: reported in about 43% of cases
- Agitation: roughly 14%
- Confusion: roughly 14%
- Slurred speech: about 13%
- Hallucinations: about 7%
- Tachycardia: about 7%
- Dizziness: about 7%
The presence of hallucinations and agitation alongside heavy sedation is notable.9Journal of Addiction Medicine. Abuse and Intentional Misuse of Promethazine Reported to US Poison Centers Phenothiazine antihistamines in high doses can produce a delirious state that some users seek deliberately. It is not the calm euphoria of an opioid; at high doses, promethazine produces something closer to a confused, dissociative state that can be disorienting and medically risky.
European adverse reaction reports show that promethazine misuse and abuse cases have been increasing over time, with a rising trend from 2003 through 2019.7Journal of Psychopharmacology. Beyond the ‘purple drank’: Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports Part of this trend likely reflects growing awareness and reporting rather than a pure increase in misuse, but the numbers are high enough that regulators have taken notice.
Drug Tests and Legal Status
If you are wondering whether promethazine will trigger a positive result on an opioid drug screen, the answer is no. Standard urine drug panels test for opioids by looking for metabolites of drugs like morphine, codeine, and oxycodone. Because promethazine works on entirely different receptors and breaks down into different metabolites, it does not cross-react with opioid assays on immunoassay-based screens. That said, someone who consumed lean would likely test positive for codeine and morphine, since codeine is metabolized into morphine. The positive result in that case comes from the codeine, not the promethazine.
Legally, promethazine occupies an unusual middle ground. In the United States, it is a prescription medication but is not classified as a controlled substance under the Controlled Substances Act. It has no DEA scheduling, which means it does not carry the same prescribing restrictions as opioids, benzodiazepines, or stimulants. You cannot buy it over the counter (a prescription is required), but pharmacies face fewer regulatory hurdles dispensing it compared to Schedule II or III drugs. In some other countries, particularly in parts of Africa and the Middle East, promethazine is available over the counter, which has contributed to higher rates of unsupervised misuse.
The lack of controlled-substance scheduling is a double-edged sword. It makes promethazine easier to prescribe for legitimate medical needs like post-operative nausea, but it also makes it easier to obtain and divert for misuse. Given the upward trend in adverse reaction reports related to abuse, some researchers and clinicians have argued that promethazine deserves closer regulatory scrutiny, or at least monitoring programs similar to those used for pseudoephedrine.
What Promethazine and Opioids Have in Common, and Where They Diverge
It is worth spelling out the overlap clearly, because the overlap is real even though the classification is not. Both promethazine and opioids can cause sedation, both can depress breathing at high doses, and both are subject to misuse. Those shared features are why the confusion persists and why the combination is so dangerous: two central nervous system depressants layered on top of each other push the body harder toward a shutdown than either would alone.
But the mechanisms behind those shared effects are fundamentally different. Opioids produce their effects through mu-opioid receptors concentrated in the brain’s pain-processing and reward circuits. Promethazine produces its sedation through histamine H1 receptor blockade and anticholinergic activity, both of which are entirely separate systems. Opioids create physical dependence through a well-characterized withdrawal syndrome involving pain, sweating, diarrhea, and intense craving. Promethazine does not produce that kind of classical physical dependence. People who misuse promethazine may develop habitual patterns of use, but the withdrawal profile, if any, looks nothing like opioid withdrawal.
Pain relief is another fundamental dividing line. Opioids are analgesics: they reduce the perception of pain. Promethazine has no meaningful analgesic effect. If you took promethazine for a broken arm, you would feel drowsy and possibly nauseous (or less nauseous, depending on the situation), but the pain would still be there. This distinction alone should settle the question for anyone who understands what opioids are designed to do.
Why the Distinction Matters for Your Safety
Getting this classification wrong is not just an academic mistake. It has practical consequences. If someone believes promethazine is an opioid, they may avoid it unnecessarily when a doctor prescribes it for legitimate nausea or allergy relief, fearing addiction or respiratory depression at normal therapeutic doses. Conversely, someone who knows promethazine is “just an antihistamine” might treat it casually and combine it with opioid painkillers without recognizing the amplified risk.
The practical guidance is straightforward. If you are prescribed promethazine for nausea, allergies, or as a pre-surgical sedative, it is not an opioid and does not carry opioid-type addiction risk at standard doses. If you are taking any opioid medication, even a low-dose prescription painkiller, tell your doctor before adding promethazine, because the combined sedation and respiratory depression risk is real and can be life-threatening. And if you encounter promethazine in a recreational context, particularly mixed into a drink with codeine syrup, understand that the danger of the mixture is greater than either ingredient alone. The promethazine is not just a filler; it is actively making the opioid component more suppressive of your ability to breathe.
Promethazine in Children and Older Adults
Two populations deserve special mention because the risks are not evenly distributed across age groups. In young children, promethazine’s respiratory depressant effects are more pronounced because the nervous system is still maturing. The FDA’s black box warning against use in children under two was driven by reports of fatal respiratory depression at standard pediatric doses.8Hospital Pharmacy. Promethazine Prescribing Patterns in Pediatric Inpatients Younger than Two Years before and after the Product Black Box Warning Many pediatric hospitals have since restricted or eliminated promethazine from their formularies for this age group, opting for ondansetron or other antiemetics with better safety profiles in small children.
In older adults, promethazine’s strong anticholinergic properties create different concerns. Anticholinergic drugs can cause confusion, urinary retention, dry mouth, constipation, and blurred vision, effects that are more burdensome and more dangerous in people over 65. Promethazine appears on the Beers Criteria, a widely used list of medications considered potentially inappropriate for older adults. This is not because it is an opioid; it is because its anticholinergic and sedative burden is high relative to safer alternatives. A geriatrician would typically choose a different antiemetic or antihistamine for an elderly patient, reserving promethazine for situations where the alternatives have failed or are not available.
Neither of these age-related risks has anything to do with opioid activity. They stem from the drug’s antihistamine and anticholinergic properties. But they are worth knowing about, because the sedation promethazine produces in these vulnerable populations can look alarming enough that a caregiver might suspect an opioid reaction when what they are actually seeing is an antihistamine reaction in someone whose body handles it poorly.